These results suggest the involvement of both the MAPK (including MEK-ERK1/2 and p38MAPK) and PI3K-Akt pathways in chemerin-induced IL-6 production by RA FLSs. The gene discussed is MAPK3; the disease is rheumatoid arthritis.